A new study authored by Jordan Stern, MD, founder and director of BlueSleep Sleep Apnea and Snoring Center based in New York, NY and Darlyne Johnson, MD, a partner at South Shore Women’s Health in Boston, MA, concluded that the BedJet climate comfort system for beds is a highly effective, non-hormonal treatment for women suffering from menopausal sleep disturbance.
The study, titled The Efficacy of the BedJet Climate System for Peri-Menopausal Night Sweat and Hot Flash Symptoms and Corresponding Impact on Sleep, will be published as an abstract in the December issue of the scientific journal Menopause: The Journal of The North American Menopause Society. Stern and Johnson presented the results during the poster session at the North American Menopause Society Conference in San Diego on October 4.
The study evaluated the effectiveness of the BedJet System in a population of 46 peri-menopausal and menopausal women experiencing hot flashes, night sweats and sleep disturbances. Effectiveness was measured using validated sleep, menopausal symptom and quality of life surveys and subjects used the BedJet System for a period of at least three weeks. The study’s primary results included:
- 94% of study participants reported improved sleep
- 89% of study participants reported improved daytime function
- 85% of study participants reported reduced hot flashes and night sweats
“Considering the known impact of poor sleep on overall health and mood, and its prevalence in menopausal women, there is an urgent need for treatment that can effectively address the problem,” Stern says in a release. “Based on the study results, the BedJet System is the first clinically proven device to be highly effective for treating poor quality of sleep in menopausal women.”
Johnson says the BedJet is a very effective alternative for women seeking relief from sleep disturbances due to hot flashes and night sweats. “This would be helpful for women who don’t want to or can’t use hormonal treatment,” she says. “Current solutions for relieving menopausal sleep disturbances and vasomotor symptoms during sleep are limited—they either have unpleasant and possibly detrimental side effects, are not conclusive in their effectiveness and are difficult treatments to adopt and comply with.”
Mark Aramli, founder and inventor of BedJet, says, “We’ve known from speaking to our customers that the BedJet has found great success in the menopausal community. It’s exciting to see that the results of this clinical study confirms the overwhelming anecdotal feedback we hear from BedJet owners every day.”